NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 19 of 19 results found.

Activity Company Description Location
Company Beam Therapeutics Activity: Production and Manufacturing Production and Manufacturing Company Description Beam Therapeutics will manufacture precision genetic medicines through the use of base editing technology at its RTP site. Location Durham
Company Bio Products Laboratory USA Inc. Activity: Sales and Operations Sales and Operations Company Description Bio Products Laboratory (BPL) manufactures and distributes plasma-derived products, including intravenous immunoglobulin preparations, coagulation factors and albumin solution. U.S. Commercial Operations for BPL are based in Durham. Location Durham
Company BioMedomics Inc. Activity: Research and Development Research and Development Company Description BioMedomics develops point-of-care (POC) diagnostics in hematology oncology, virology, women’s health and dermatology. Location Durham
Company Cato SMS Activity: Contract Research and Testing Contract Research and Testing Company Description Cato SMS provides contract research services, including preclinical and clinical study design and management, regulatory assessments, data management and statistics, CMC program management, medical writing and submission of regulatory documents. Location Cary
Company Cellectis Activity: Production and Manufacturing Production and Manufacturing Company Description Cellectis develops blood and bone marrow cancer cell therapies. The Raleigh location is its North American manufacturing plant. Location Raleigh
Company Dova Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Dova Pharmaceuticals, a subsidiary of Swedish Orphan Biovitrum AB (Sobi), develops treatments for orphan diseases. Its lead compound is a treatment for thrombocytopenia in patients with chronic liver disease. Location Durham
Company Entegrion Inc. Activity: Research and Development Research and Development Company Description Entegrion develops biologic and medical device technologies, such as a novel point of care in vitro diagnostic viscoelastic blood coagulation monitoring system for use in human and veterinary medicine. Location Durham
Company Gateway Bio Inc. Activity: Research and Development Research and Development Company Description Gateway Bio is developing a rapid onset anticoagulant. Location Durham
Company GeneVentiv Therapeutics Inc. Activity: Research and Development Research and Development Company Description GeneVentiv Therapeutics is a gene therapy company developing a cure for Hemophilia A, Hemophilia B or Factor VIII deficiency, with or without inhibitors. Location Raleigh
Company Grifols Activity: Sales and Operations Sales and Operations Company Description Grifols manufactures and markets plasma-derived medicines to treat chronic and acute conditions in the therapeutic areas of immunology, pulmonology, hematology, thrombolytics and neurology. Location Research Triangle Park
Company Grifols (Clayton) Activity: Production and Manufacturing Production and Manufacturing Company Description Grifols' manufacturing campus in Clayton produces plasma-derived medicines for the treatment of a number of rare, genetic, chronic and potentially life-threatening conditions. Location Clayton
Company Helixomer Inc. Activity: Research and Development Research and Development Company Description Helixomer is developing RNA-based anticoagulants. Location Raleigh
Company Hemo Bioscience Inc. Activity: Production and Manufacturing Production and Manufacturing Company Description Hemo Bioscience is an FDA-registered, ISO 13485-accredited manufacturer of blood-typing reagents and diagnostics for the blood-banking industry. Location Durham
Company HemoSonics LLC Activity: Research and Development Research and Development Company Description HemoSonics is developing an in vitro diagnostic platform that measures the evolving stiffness of forming blood clots within a consumable test cartridge. Its technology assists with the management of coagulation dysfunctions at the point of care. Location Durham
Company Immunovant Inc. Activity: Research and Development Research and Development Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. Location Durham
Company Indexus Biomedical LLC Activity: Research and Development Research and Development Company Description Indexus Biomedical designs, develops and manufactures instrument systems, reagents and assays for in vitro diagnostics, initially focusing on the hematology and immunology markets. Location Morrisville
Company Kalia Health Activity: Research and Development Research and Development Company Description Kalia Health develops home-based early detection tests for pregnancy complications like preeclampsia and eclampsia for use in low-resource settings. Location Chapel Hill
Company Meryx Inc. Activity: Research and Development Research and Development Company Description Meryx is developing small-molecule, orally-bioavailable RTK inhibitors that inhibit growth and initiate anti-tumor immunity in hematologic and solid malignancies. Location Chapel Hill
Company Tenax Therapeutics Inc. Activity: Research and Development Research and Development Company Description Tenax Therapeutics develops and commercializes pharmaceutical products for the critical care market. Location Morrisville